Literature DB >> 617574

The therapeutic use of glucocorticoid hormones in the perinatal period: potential neurological hazards.

M E Weichsel.   

Abstract

The expanding perinatal use of glucocorticoids entails potentially hazardous effects of these hormones on nervous system development. Neonatal animal experimentation with pharmacological doses of glucocorticoids has revealed immediate effects on brain cell division, differentiation, myelination, and electrophysiological reactions. In addition, delayed (latent) effects include changes in control of circadian periodicity, altered biogenic amine levels, altered response to stress, and changes in ultimate behavior. Thus perinatal hormone therapy during critical periods of brain development is capable of exerting irreversible immediate effects on brain cell division and differentiation, resulting in latent or long-term physiological and behavioral effects.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 617574     DOI： 10.1002/ana.410020503

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


  19 in total

Review 1.  Weaning from assisted ventilation: art or science?

Authors:  S K Sinha; S M Donn
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-07       Impact factor: 5.747

2.  Hazards of systemic steroids for ventilator-dependent preterm infants: what would a parent want?

Authors:  K J Barrington
Journal:  CMAJ       Date:  2001-07-10       Impact factor: 8.262

Review 3.  Postnatal steroid treatment and brain development.

Authors:  O Baud
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-03       Impact factor: 5.747

4.  Death or neurodevelopmental impairment at 18 to 22 months corrected age in a randomized trial of early dexamethasone to prevent death or chronic lung disease in extremely low birth weight infants.

Authors:  Ann R Stark; Waldemar A Carlo; Betty R Vohr; Lu Ann Papile; Shampa Saha; Charles R Bauer; William Oh; Seetha Shankaran; Jon E Tyson; Linda L Wright; W Kenneth Poole; Abhik Das; Barbara J Stoll; Avroy A Fanaroff; Sheldon B Korones; Richard A Ehrenkranz; David K Stevenson; Myriam Peralta-Carcelen; Deanne E Wilson-Costello; Henrietta S Bada; Roy J Heyne; Yvette R Johnson; Kimberly Gronsman Lee; Jean J Steichen
Journal:  J Pediatr       Date:  2013-08-27       Impact factor: 4.406

5.  Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease.

Authors:  T Bhuta; A Ohlsson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-07       Impact factor: 5.747

6.  Randomised controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome.

Authors:  T F Fok; K Lam; M Dolovich; P C Ng; W Wong; K L Cheung; K W So
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-05       Impact factor: 5.747

Review 7.  The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.

Authors:  P C Ng
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

8.  Cumulative perinatal steroids: child development of preterm infants.

Authors:  Isabell B Purdy; Dorothy J Wiley; Lynne M Smith; Carollee Howes; Anna Gawlinski; Wendy Robbins; Lina K Badr
Journal:  J Pediatr Nurs       Date:  2008-06       Impact factor: 2.145

Review 9.  Neurologic development of children with severe chronic renal failure from infancy.

Authors:  M S Polinsky; B A Kaiser; J B Stover; M Frankenfield; H J Baluarte
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

Review 10.  Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

Authors:  Lex W Doyle; Jeanie L Cheong; Richard A Ehrenkranz; Henry L Halliday
Journal:  Cochrane Database Syst Rev       Date:  2017-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.